Remote Jobs at Noctrix Health, Inc.
Noctrix Health, Inc.
11 - 50 employees
Founded 2018
🏥 Healthcare
🔧 Hardware
🔥 Funding within the last year
💰 $33.5M Venture Round - Noctrix Health on 2025-08
Healthcare • Hardware
Noctrix Health, Inc. is developing the next generation of clinically validated wearable therapeutics to manage chronic neurological disorders, focused initially on Restless Legs Syndrome (RLS). Their prescription-grade wearable therapy, marketed as Nidra (Tonic Motor Activation, TOMAC), has earned FDA Breakthrough Device designation (June 2020), a De Novo decision (April 2023), and had a pivotal RESTFUL trial published in SLEEP (July 2023). The company began commercial shipments in mid‑2023 and achieved dedicated CMS HCPCS reimbursement codes and payments for Nidra and supplies in October 2024. Noctrix combines medical-device expertise with neuroscientists and consumer-electronics engineers to deliver clinically validated, patient-facing wearable medical devices.
Is on LinkedIn?
